Literature DB >> 35747866

ENDOCRINE DISRUPTING CHEMICALS AND OBESITY: THE EVOLVING STORY OF OBESOGENS.

D Micić3, S Polovina2, D Micić3, D Macut4.   

Abstract

Increase in obesity pandemic all over the world consequently leads to the investigation of possible causes. In addition to the traditional explanation using the so-called caloric model, the field of endocrine disruptors (EDs), especially subgroup called obesogens, offered more light on the pathogenetic mechanisms involved. After the Second World War a correlation between an increased production of exogenous pollutants and actual obesity epidemic was suggested. "Obesogen hypothesis" implies that molecules called obesogens inadequately stimulate the development of adipose cells and lipid accumulation in existing adipose cells, as well as change metabolic balance or hormonal control of appetite and satiety, leading to an increase in body fat mass. The list of obesogens includes some industrial chemicals, biocides, pharmaceuticals, pollutants, and smoke. EDs from the group of obesogens may exert their effects by the impairment in the programming development of adipocytes, by an increase in energetic depot in the adipose tissue, and by influencing neuroendocrine control of appetite and satiety. Increased scientific evidence on obesogens and their mechanisms of action may help to prevent obesity and mitigate deleterious effects of the environment on human life and development. New translational studies are needed to explain the possible mechanism proposed. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  adipocyte; endocrine disrupting chemicals; microbiota; obesity; obesogens

Year:  2021        PMID: 35747866      PMCID: PMC9206156          DOI: 10.4183/aeb.2021.503

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  42 in total

1.  Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.

Authors:  Felix Grün; Hajime Watanabe; Zamaneh Zamanian; Lauren Maeda; Kayo Arima; Ryan Cubacha; David M Gardiner; Jun Kanno; Taisen Iguchi; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2006-04-13

Review 2.  Endocrine disruptors and gut microbiome interactions.

Authors:  R Hampl; L Stárka
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 3.  Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2021-11-22       Impact factor: 3.443

Review 4.  Obesogens: an emerging threat to public health.

Authors:  Amanda S Janesick; Bruce Blumberg
Journal:  Am J Obstet Gynecol       Date:  2016-01-29       Impact factor: 8.661

5.  The impact of endocrine disruption: a consensus statement on the state of the science.

Authors:  Ake Bergman; Jerrold J Heindel; Tim Kasten; Karen A Kidd; Susan Jobling; Maria Neira; R Thomas Zoeller; Georg Becher; Poul Bjerregaard; Riana Bornman; Ingvar Brandt; Andreas Kortenkamp; Derek Muir; Marie-Noël Brune Drisse; Roseline Ochieng; Niels E Skakkebaek; Agneta Sundén Byléhn; Taisen Iguchi; Jorma Toppari; Tracey J Woodruff
Journal:  Environ Health Perspect       Date:  2013-04       Impact factor: 9.031

6.  Ancestral perinatal obesogen exposure results in a transgenerational thrifty phenotype in mice.

Authors:  Raquel Chamorro-Garcia; Carlos Diaz-Castillo; Bassem M Shoucri; Heidi Käch; Ron Leavitt; Toshi Shioda; Bruce Blumberg
Journal:  Nat Commun       Date:  2017-12-08       Impact factor: 14.919

Review 7.  Endocrine Disruptors in Food: Impact on Gut Microbiota and Metabolic Diseases.

Authors:  Yolanda Gálvez-Ontiveros; Sara Páez; Celia Monteagudo; Ana Rivas
Journal:  Nutrients       Date:  2020-04-21       Impact factor: 5.717

Review 8.  Importance of gut microbiota in obesity.

Authors:  Isabel Cornejo-Pareja; Araceli Muñoz-Garach; Mercedes Clemente-Postigo; Francisco J Tinahones
Journal:  Eur J Clin Nutr       Date:  2019-07       Impact factor: 4.016

9.  Tributyltin differentially promotes development of a phenotypically distinct adipocyte.

Authors:  Shane M Regnier; Essam El-Hashani; Wakanene Kamau; Xiaojie Zhang; Nicole L Massad; Robert M Sargis
Journal:  Obesity (Silver Spring)       Date:  2015-08-04       Impact factor: 5.002

10.  Developmental exposure to DDT or DDE alters sympathetic innervation of brown adipose in adult female mice.

Authors:  Annalise N vonderEmbse; Sarah E Elmore; Kyle B Jackson; Beth A Habecker; Katherine E Manz; Kurt D Pennell; Pamela J Lein; Michele A La Merrill
Journal:  Environ Health       Date:  2021-04-01       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.